A detailed history of Ubs Group Ag transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 52,501 shares of ADGI stock, worth $173,778. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,501
Previous 24,104 117.81%
Holding current value
$173,778
Previous $79,000 118.99%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
28,397 Added 117.81%
52,501 $173,000
Q2 2024

Aug 13, 2024

BUY
N/A
22,736 Added 1661.99%
24,104 $79,000
Q1 2024

May 13, 2024

SELL
N/A
-13,089 Reduced 90.54%
1,368 $4,000
Q4 2023

Feb 09, 2024

BUY
N/A
13,308 Added 1158.22%
14,457 $47,000
Q3 2023

Nov 09, 2023

SELL
N/A
-435 Reduced 27.46%
1,149 $3,000
Q2 2023

Aug 11, 2023

SELL
N/A
-16,906 Reduced 91.43%
1,584 $5,000
Q1 2023

May 12, 2023

BUY
N/A
2,284 Added 14.09%
18,490 $61,000
Q4 2022

Feb 08, 2023

BUY
$3.08 - $4.05 $46,960 - $61,750
15,247 Added 1589.89%
16,206 $53,000
Q3 2022

Nov 10, 2022

SELL
$2.97 - $4.83 $397 - $647
-134 Reduced 12.26%
959 $3,000
Q2 2022

Aug 10, 2022

SELL
$2.54 - $4.52 $27,406 - $48,770
-10,790 Reduced 90.8%
1,093 $4,000
Q1 2022

May 16, 2022

SELL
$3.81 - $10.77 $318,839 - $901,287
-83,685 Reduced 87.57%
11,883 $54,000
Q4 2021

Feb 14, 2022

BUY
$6.35 - $47.04 $606,856 - $4.5 Million
95,568 New
95,568 $694,000

Others Institutions Holding ADGI

About Adagio Therapeutics, Inc.


  • Ticker ADGI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,831,000
  • Market Cap $505M
  • Description
  • Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...
More about ADGI
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.